Publicerat: 2022-01-18 10:56:34

Inhalation Sciences: Submits Whitepaper to the FDA - Redeye

Redeye endorses ISAB submitting a whitepaper to the FDA in order to establish the DissolvIt lung model as an FDA-recommended standard research method in the US. We see an interesting year ahead and continue to argue that the share is attractive at current share price levels.

Länk till analysen

Läs mer om Inhalation Sciences Sweden AB